Packed red blood cells inhibit T-cell activation via ROS-dependent signaling pathways

Autor: Andrea Bileck, Pierre Raeven, Liesa S. Ziegler, Christopher Gerner, Marlene C. Gerner, David M. Baron, Ernst W. Müllner, Thomas Öhlinger, Ulrich Salzer, Klaus G. Schmetterer, Lukas Janker
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Antigens
Differentiation
T-Lymphocyte

0301 basic medicine
Erythrocytes
T-Lymphocytes
PRBCs
packed red blood cells

Lymphocyte Activation
Biochemistry
T-cell
FACS
fluorescence-activated cell sorting

Phosphorylation
CPD
cell proliferation dye

Cells
Cultured

FA
formic acid

chemistry.chemical_classification
reactive oxygen species
immunosuppression
biology
Chemistry
mTOR
mechanistic target of rapamycin

TMRE
tetramethylrhodamine ethyl ester

CD28
phosphoproteomics
DCFDA
2′
7′-dichlorofluorescin diacetate

Cell biology
H2O2
hydrogen peroxide

Second messenger system
Signal transduction
Signal Transduction
Research Article
CD3
PBMCs
peripheral blood–derived mononuclear cells

Immunomodulation
redox regulation
03 medical and health sciences
ROS
reactive oxygen species

Antigens
CD

IL-2
interleukin-2

Humans
Lectins
C-Type

NaN3
sodium azide

Molecular Biology
PI3K/AKT/mTOR pathway
Cell Proliferation
IC
intracellular

Reactive oxygen species
030102 biochemistry & molecular biology
T-cell receptor
Interleukin-2 Receptor alpha Subunit
NAC
N-acetyl-l-cysteine

Cell Biology
ACN
acetonitrile

PE
phycoerythrin

030104 developmental biology
TCR
T-cell receptor

Leukocytes
Mononuclear

RBCs
red blood cells

biology.protein
FCS
fetal calf serum

erythrocyte
Zdroj: The Journal of Biological Chemistry
Popis: Numerous observations indicate that red blood cells (RBCs) affect T-cell activation and proliferation. We have studied effects of packed RBCs (PRBCs) on T-cell receptor (TCR) signaling and the molecular mechanisms whereby (P)RBCs modulate T-cell activation. In line with previous reports, PRBCs attenuated the expression of T-cell activation markers CD25 and CD69 upon costimulation via CD3/CD28. In addition, T-cell proliferation and cytokine expression were markedly reduced when T-cells were stimulated in the presence of PRBCs. Inhibitory activity of PRBCs required direct cell–cell contact and intact PRBCs. The production of activation-induced cellular reactive oxygen species, which act as second messengers in T-cells, was completely abrogated to levels of unstimulated T-cells in the presence of PRBCs. Phosphorylation of the TCR-related zeta chain and thus proximal TCR signal transduction was unaffected by PRBCs, ruling out mechanisms based on secreted factors and steric interaction restrictions. In large part, downstream signaling events requiring reactive oxygen species for full functionality were affected, as confirmed by an untargeted MS-based phosphoproteomics approach. PRBCs inhibited T-cell activation more efficiently than treatment with 1 mM of the antioxidant N-acetyl cysteine. Taken together, our data imply that inflammation-related radical reactions are modulated by PRBCs. These immunomodulating effects may be responsible for clinical observations associated with transfusion of PRBCs.
Databáze: OpenAIRE